Top Markets
Coin of the day
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc.

CPMV
Pozycja w akcjach #38778
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to... Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
Cena akcji
$0.106
Ostatnia synchronizacja: 2026-10-01
Kapitalizacja rynkowa
$767.67K
Zmiana (1 dzień)
73.77%
Zmiana (1 rok)
-84.81%
Kraj
US
Handel Mosaic ImmunoEngineering Inc. (CPMV)

Kategoria

Historia stopy dywidendy dla Mosaic ImmunoEngineering Inc. (CPMV)
Stopa dywidendy (TTM) dla Mosaic ImmunoEngineering Inc. (symbol akcji: CPMV) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Mosaic ImmunoEngineering Inc. (CPMV) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji